Follow the 코렌텍 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 코렌텍 has published 144 reports. The latest transaction was filed on 11 June 2026 (Purchase). Among the most active insiders: 선경훈. Every trade is accessible without an account.
144
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Koreantec is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of medical devices.